Ocular Therapeutix (OCUL) Has $598.6M as Its Eye Drug Approaches a Filing Milestone
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Nuvation Bio (NUVB) Drug Sales Climb 25%!
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Taysha (TSHA) Raises $230M for a Gene Therapy Story With Plenty Still to Prove
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Absci (ABSI) Raises $100M as Its AI Hair Loss Treatment Faces the Proof Test
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Savara (SVRA) Has $173M and a November FDA Date That Could Rewrite Its Story
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Maravai (MRVI)’s mRNA Business Grows 37.3%
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Recursion (RXRX) Lands a $10M Milestone as Its AI Drug Discovery Story Gets Real
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
ImmunityBio (IBRX) Sales Jump 121% as Its Cancer Drug Gets a Bigger Playing Field
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Precigen (PGEN) Turns $74.7M in Drug Sales Into a Profit Story Worth Watching
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
Immatics (IMTX) Has $448M in Cash and a 56% Cancer Response Rate
Wall Street likes biotechnology stocks for a familiar reason: promising science can eventually become profitable medicine. A breakthrough…
10 Best Biotech Stocks Under $10 to Buy Now
Wall Street’s appetite for biotechnology stocks has a familiar starting point: promising science with the potential to become…
5 Best Biotech Stocks Under $10 to Buy Now
5. Savara Inc. (NASDAQ:SVRA) Number of Hedge Fund Holders: 36Market Capitalization: $1.03 billionShare Price: $4.86 Savara Inc. (NASDAQ:…